Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
Biotech
Biotech
Zealand's dual agonist tied to 11% weight loss in phase 1b
A higher dose of Zealand Pharma's GLP-1/GLP-2 receptor dual agonist reduced mean body weight by 11.6% after 28 weeks in a phase 1b trial.
Gabrielle Masson
Jun 18, 2025 3:00pm
Fierce Biotech Layoff Tracker 2025: BioNTech, Gilead & more
Jun 18, 2025 12:43pm
Sponsored
Unlocking the power of biospecimens
Jun 16, 2025 8:00am
US accused of ending grants for biotechs with Chinese investors
Jun 18, 2025 11:50am
Sponsored
Carl Sailer on AI, market trends, and strategic planning in biotech
Oct 28, 2024 8:00pm
Taxes, tariffs, interest rates hold key to biotech's future: EY
Jun 18, 2025 9:50am
